Pharming Group N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
20 mar 2025 - 07:00
Statutory name
Pharming Group N.V.
Title
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
Date last update: 09 May 2025